Entero Healthcare Solutions

Entero Healthcare delivered a strong FY26, with revenue of ₹6,591 croreCurrent reported value: ₹6,591 crore. No comparable prior figure is available in the source record. growing 31.5Current 31.5 crore vs previous available quarter 28 crore.% YoY on a like-for-like basis, driven by 15.6% organic growth and 16% inorganic contribution. EBITDA margin expanded 67 bps to 4.0%Current 4% vs previous available quarter 4%., aided by gross margin improvement of 78 bps to 10.3%. PAT grew 36Current reported value: 36. No comparable prior figure is available in the source record.% to ₹146 croreCurrent reported value: ₹146 crore. No comparable prior figure is available in the source record.. Q4Current 4 crore vs previous available quarter 4 crore. revenue surged 42.6% YoY, with EBITDA margin at 4.5%. Management guided for FY27 consolidated revenue growth of 23%Current reported value: 23%. No comparable prior figure is available in the source record. (excluding new M&A) and EBITDA margin of 5%Current reported value: 5%. No comparable prior figure is available in the source record., with operating cash flow conversion of at least 50% of EBITDA. The medtech segment now contributes over ₹1,000 crore in annualized revenue. Key risks include potential margin dilution from minority interest (guided ~25% of PAT) and integration challenges from recent acquisitions.